Rapid Antigen Test (RAT) showed an excellent specificity to 'rule-in' COVID-19 patients within the first 5 days of illness and had a moderate sensitivity. Therefore, patients showing positive results need to be immediately triaged and those with negative tests should be reconfirmed by an rRT-PCR.
Nano-formulations of dexamethasone administered either IV or via inhalation may help to improve COVID-19 treatment outcomes. This editorial summarizes how we can improve our Covid-19 treatment options further by potentiating the already established anti-edema activity and anti-fibrotic effects of free dexamethasone via nanomedicine.
Last year, The Lancet Series aimed to get global oral health on global health agendas. On 25 June 2020, The Lancet announced that 27 experts across research, policy, advocacy & clinical dentistry from 16 countries will continue this work via a Lancet Commission on Oral Health. Dr Divyesh Mundra gives more details on the Lancet Health Commission and its plans.